Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,482
Closed -$32.4K 1041
2022
Q1
$32.4K Hold
4,482
0.01% 618
2021
Q4
$23.8K Hold
4,482
0.01% 568
2021
Q3
$20.5K Hold
4,482
﹤0.01% 680
2021
Q2
$17.8K Hold
4,482
﹤0.01% 715
2021
Q1
$18.6K Hold
4,482
0.01% 570
2020
Q4
$10.4K Hold
4,482
﹤0.01% 524
2020
Q3
$5.39K Hold
4,482
﹤0.01% 498
2020
Q2
$7.21K Hold
4,482
﹤0.01% 430
2020
Q1
$3.43K Hold
4,482
﹤0.01% 475
2019
Q4
$19.3K Hold
4,482
﹤0.01% 395
2019
Q3
$19.1K Hold
4,482
﹤0.01% 401
2019
Q2
$14.8K Hold
4,482
﹤0.01% 438
2019
Q1
$14.5K Hold
4,482
﹤0.01% 375
2018
Q4
$13.6K Hold
4,482
﹤0.01% 447
2018
Q3
$28K Hold
4,482
0.01% 399
2018
Q2
$32.4K Hold
4,482
0.01% 405
2018
Q1
$31.5K Hold
4,482
0.01% 376
2017
Q4
$34.2K Hold
4,482
0.01% 365
2017
Q3
$36.1K Hold
4,482
0.01% 332
2017
Q2
$34.3K Hold
4,482
0.01% 341
2017
Q1
$48.7K Hold
4,482
0.01% 267
2016
Q4
$60.8K Hold
4,482
0.01% 283
2016
Q3
$58.9K Hold
4,482
0.01% 285
2016
Q2
$70.6K Hold
4,482
0.01% 260
2016
Q1
$62.2K Hold
4,482
0.01% 281
2015
Q4
$52K Hold
4,482
0.01% 258
2015
Q3
$50.2K Hold
4,482
0.01% 263
2015
Q2
$91.7K Sell
4,482
-76
-2% -$1.78K 0.01% 251
2015
Q1
$99.6K Buy
4,558
+1,717
+60% +$39.1K 0.01% 265
2014
Q4
$62.6K Buy
+2,841
New +$77.4K 0.01% 314

Other funds holding VRN

Exane Derivatives's VRN Position: Q2 2022 in Review

Exane Derivatives sold out of Veren (VRN) in Q2 2022, closing a stake of 4,482 shares — an estimated $32.4K sold.

Exane Derivatives first reported a position in VRN in Q4 2014 and held it in 30 quarters. The position peaked at $99.6K in Q1 2015. 180 funds tracked by Wall St. Rank hold VRN as of Q2 2022.

  • Exane Derivatives reported no remaining Veren position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 4,482 Veren shares in Q2 2022, an estimated $32.4K.
  • Exane Derivatives first reported a position in Veren in Q4 2014 and held it in 30 quarters.
  • Exane Derivatives's Veren position peaked at $99.6K in Q1 2015.
  • 180 funds tracked by Wall St. Rank held Veren as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.